Evidence map›Paper›PMID 30154062›Full record

ArticleJACC. Cardiovascular interventions2018

Coronary Hemodynamics in Patients With Severe Aortic Stenosis and Coronary Artery Disease Undergoing Transcatheter Aortic Valve Replacement: Implications for Clinical Indices of Coronary Stenosis Severity.

Yousif Ahmad, Matthias Götberg, Christopher Cook, James P Howard, Iqbal Malik, Ghada Mikhail, Angela Frame, Ricardo Petraco, Christopher Rajkumar, Ozan Demir and 18 more

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in JACC. Cardiovascular interventions, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 126 citations in OpenAlex.

  1. Progression of Coronary Artery Disease in Patients Undergoing Transcatheter Aortic Valve Replacement: A Quantitative Coronary Angiography and Quantitative Flow Ratio Analysis.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Coronary Artery Disease and Transcatheter Aortic Valve Replacement.Journal of the Society for Cardiovascular Angiography & Interventions · 2025
    Review
  12. Article
  13. Review
  14. Article
  15. Absolute coronary flow and microvascular resistance before and after transcatheter aortic valve implantation.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2024
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

28 authors at 8 institutions in 5 countries.

Yousif AhmadNational Heart and Lung Institute, Hammersmith Hospital, Imperial College London, London, United Kingdom.
Matthias GötbergDepartment of Cardiology, Clinical Sciences, Lund University, Skåne University Hospital, Sweden.
Christopher CookNational Heart and Lung Institute, Hammersmith Hospital, Imperial College London, London, United Kingdom.
James P HowardNational Heart and Lung Institute, Hammersmith Hospital, Imperial College London, London, United Kingdom.
Iqbal MalikDepartment of Cardiology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
Ghada MikhailDepartment of Cardiology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
Angela FrameDepartment of Cardiology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
Ricardo PetracoNational Heart and Lung Institute, Hammersmith Hospital, Imperial College London, London, United Kingdom.
Christopher RajkumarNational Heart and Lung Institute, Hammersmith Hospital, Imperial College London, London, United Kingdom.
Ozan DemirDepartment of Cardiology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
Juan F IglesiasCardiology Department, Lausanne University Hospital, Lausanne, Switzerland.
Ravinay BhindiDepartment of Cardiology, Royal North Shore Hospital, Sydney, Australia.
Sasha KoulDepartment of Cardiology, Clinical Sciences, Lund University, Skåne University Hospital, Sweden.
Nearchos HadjiloizouDepartment of Cardiology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
Robert GerberDepartment of Cardiology, Conquest Hospital, St. Leonards-on-Sea, United Kingdom.
Punit RamrakhaDepartment of Cardiology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
Neil RupareliaDepartment of Cardiology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
Nilesh SutariaDepartment of Cardiology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
Gajen KanaganayagamDepartment of Cardiology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
Ben AriffDepartment of Cardiology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
Michael FertlemanDepartment of Cardiology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
Jon AndersonDepartment of Cardiology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
Andrew ChukwuemekaDepartment of Cardiology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
Darrel FrancisNational Heart and Lung Institute, Hammersmith Hospital, Imperial College London, London, United Kingdom.
Jamil MayetNational Heart and Lung Institute, Hammersmith Hospital, Imperial College London, London, United Kingdom.
Patrick SerruysNational Heart and Lung Institute, Hammersmith Hospital, Imperial College London, London, United Kingdom.
Justin DaviesNational Heart and Lung Institute, Hammersmith Hospital, Imperial College London, London, United Kingdom.
Sayan SenNational Heart and Lung Institute, Hammersmith Hospital, Imperial College London, London, United Kingdom. Electronic address: sayan.sen@imperial.ac.uk.
Hammersmith Hospital · GBImperial College London · GBImperial College Healthcare NHS Trust · GBLund University · SEConquest Hospital · GBLung Institute · USRoyal North Shore Hospital · AUUniversity of Lausanne · CH

Funding

British Heart Foundation FS 04/079British Heart Foundation FS/11/46/28861Medical Research Council G1000357Medical Research Council MR/M018369/1Wellcome Trust
6 · The paper itself

Abstract

objectivesIn this study, a systematic analysis was conducted of phasic intracoronary pressure and flow velocity in patients with severe aortic stenosis (AS) and coronary artery disease, undergoing transcatheter aortic valve replacement (TAVR), to determine how AS affects: 1) phasic coronary flow; 2) hyperemic coronary flow; and 3) the most common clinically used indices of coronary stenosis severity, instantaneous wave-free ratio and fractional flow reserve.

backgroundA significant proportion of patients with severe aortic stenosis (AS) have concomitant coronary artery disease. The effect of the valve on coronary pressure, flow, and the established invasive clinical indices of stenosis severity have not been studied.

methodsTwenty-eight patients (30 lesions, 50.0% men, mean age 82.1 ± 6.5 years) with severe AS and coronary artery disease were included. Intracoronary pressure and flow assessments were performed at rest and during hyperemia immediately before and after TAVR.

resultsFlow during the wave-free period of diastole did not change post-TAVR (29.78 ± 14.9 cm/s vs. 30.81 ± 19.6 cm/s; p = 0.64). Whole-cycle hyperemic flow increased significantly post-TAVR (33.44 ± 13.4 cm/s pre-TAVR vs. 40.33 ± 17.4 cm/s post-TAVR; p = 0.006); this was secondary to significant increases in systolic hyperemic flow post-TAVR (27.67 ± 12.1 cm/s pre-TAVR vs. 34.15 ± 17.5 cm/s post-TAVR; p = 0.02). Instantaneous wave-free ratio values did not change post-TAVR (0.88 ± 0.09 pre-TAVR vs. 0.88 ± 0.09 post-TAVR; p = 0.73), whereas fractional flow reserve decreased significantly post-TAVR (0.87 ± 0.08 pre-TAVR vs. 0.85 ± 0.09 post-TAVR; p = 0.001).

conclusionsSystolic and hyperemic coronary flow increased significantly post-TAVR; consequently, hyperemic indices that include systole underestimated coronary stenosis severity in patients with severe AS. Flow during the wave-free period of diastole did not change post-TAVR, suggesting that indices calculated during this period are not vulnerable to the confounding effect of the stenotic aortic valve.

Indexed as

Cardiac CatheterizationFractional Flow Reserve, MyocardialHemodynamicsTranscatheter Aortic Valve ReplacementAgedAged, 80 and overAortic Valve StenosisBlood Flow VelocityCoronary Artery DiseaseCoronary StenosisFemaleHumansHyperemiaLondonMalePredictive Value of Testsaortic stenosiscoronary flowfractional flow reserveinstantaneous wave-free ratioTAVR

Identifiers

PMID30154062
PMCPMC6197079
OpenAlexW2888691009

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.